Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8837 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8837 |
High Similarity |
NPD5124 |
Phase 1 |
0.878 |
High Similarity |
NPD422 |
Phase 1 |
0.8308 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8136 |
Intermediate Similarity |
NPD9697 |
Approved |
0.8115 |
Intermediate Similarity |
NPD5535 |
Approved |
0.8088 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7986 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7939 |
Intermediate Similarity |
NPD2797 |
Approved |
0.791 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7899 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7874 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7863 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7803 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7803 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7769 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7704 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7652 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7635 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7634 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7615 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7606 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD920 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7533 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7517 |
Intermediate Similarity |
NPD6799 |
Approved |
0.75 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7344 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7313 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7285 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7252 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD919 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD17 |
Approved |
0.7206 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7203 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7154 |
Intermediate Similarity |
NPD940 |
Approved |
0.7154 |
Intermediate Similarity |
NPD846 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7092 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7068 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7032 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7031 |
Intermediate Similarity |
NPD5451 |
Approved |
0.702 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7014 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7007 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7 |
Intermediate Similarity |
NPD7843 |
Approved |
0.6993 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1933 |
Approved |
0.6987 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6986 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6985 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD2798 |
Approved |
0.6978 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6387 |
Discontinued |
0.6962 |
Remote Similarity |
NPD5494 |
Approved |
0.6959 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD1511 |
Approved |
0.6933 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6929 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD3226 |
Approved |
0.6923 |
Remote Similarity |
NPD1137 |
Approved |
0.6923 |
Remote Similarity |
NPD1139 |
Approved |
0.6918 |
Remote Similarity |
NPD4477 |
Approved |
0.6918 |
Remote Similarity |
NPD4476 |
Approved |
0.6912 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6909 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6889 |
Remote Similarity |
NPD5585 |
Approved |
0.6887 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD290 |
Approved |
0.6875 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.687 |
Remote Similarity |
NPD1138 |
Approved |
0.6861 |
Remote Similarity |
NPD1281 |
Approved |
0.6861 |
Remote Similarity |
NPD1091 |
Approved |
0.6859 |
Remote Similarity |
NPD2801 |
Approved |
0.6857 |
Remote Similarity |
NPD3691 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD3690 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD7003 |
Approved |
0.6842 |
Remote Similarity |
NPD1512 |
Approved |
0.6842 |
Remote Similarity |
NPD7157 |
Approved |
0.6842 |
Remote Similarity |
NPD2557 |
Approved |
0.6839 |
Remote Similarity |
NPD5890 |
Approved |
0.6839 |
Remote Similarity |
NPD5889 |
Approved |
0.6835 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6835 |
Remote Similarity |
NPD6696 |
Suspended |
0.6831 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6828 |
Remote Similarity |
NPD6651 |
Approved |
0.6818 |
Remote Similarity |
NPD592 |
Approved |
0.6818 |
Remote Similarity |
NPD594 |
Approved |
0.6815 |
Remote Similarity |
NPD6580 |
Approved |
0.6815 |
Remote Similarity |
NPD6581 |
Approved |
0.6815 |
Remote Similarity |
NPD9545 |
Approved |
0.6812 |
Remote Similarity |
NPD3972 |
Approved |
0.6812 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6809 |
Remote Similarity |
NPD2237 |
Approved |
0.6803 |
Remote Similarity |
NPD2862 |
Discontinued |
0.6795 |
Remote Similarity |
NPD1934 |
Approved |
0.6791 |
Remote Similarity |
NPD3596 |
Phase 2 |
0.679 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6786 |
Remote Similarity |
NPD987 |
Approved |
0.6783 |
Remote Similarity |
NPD3764 |
Approved |
0.6783 |
Remote Similarity |
NPD411 |
Approved |
0.6779 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD2335 |
Discontinued |
0.677 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6768 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6765 |
Remote Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD1651 |
Approved |
0.6763 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6763 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6763 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6761 |
Remote Similarity |
NPD2614 |
Approved |
0.6759
|
Remote Similarity |
NPD4618 |
Approved |